Can TMS Therapy Help with Anxiety? What Current Research Shows

Key Takeaways

TMS therapy is FDA-cleared for major depressive disorder and obsessive-compulsive disorder (OCD) only. It is not FDA-cleared for treating anxiety disorders.
Many patients with depression also have co-occurring anxiety, and treating depression with TMS may lead to improvement in anxiety symptoms as well.
Emerging research, including published meta-analyses, suggests TMS may reduce anxiety symptoms, but the evidence is not yet strong enough for FDA clearance.
Any use of TMS specifically targeting anxiety is considered off-label and should be discussed thoroughly with your psychiatrist.
Diamond Edge TMS in Vancouver, WA provides comprehensive psychiatric evaluation to determine whether TMS therapy may be appropriate for your situation. Schedule an appointment to discuss your options.

Understanding Anxiety Disorders

Anxiety disorders are among the most common mental health conditions in the United States, affecting approximately 40 million adults each year. While everyone experiences occasional worry or nervousness, anxiety disorders involve persistent, excessive fear or worry that interferes with daily activities, relationships, and overall quality of life.

There are several distinct anxiety disorders, each with its own characteristics:

Generalized anxiety disorder (GAD) involves chronic, exaggerated worry about everyday matters such as health, finances, work, or family, often without a clear cause.
Panic disorder is marked by sudden, repeated episodes of intense fear accompanied by physical symptoms like racing heart, shortness of breath, and dizziness.
Social anxiety disorder causes significant fear and avoidance of social situations due to concerns about judgment or embarrassment.
Specific phobias involve intense, irrational fear of particular objects or situations.

Standard treatments for anxiety disorders include psychotherapy (particularly cognitive behavioral therapy), medication management with SSRIs or SNRIs, and lifestyle modifications. These approaches are effective for many people, but a significant number of patients do not achieve adequate relief with first-line treatments. This treatment gap has led researchers and clinicians to explore whether TMS could offer another option.

How TMS Works for Depression (and Why Anxiety May Improve)

Transcranial magnetic stimulation works by delivering focused magnetic pulses to specific areas of the brain. For depression treatment, the standard protocol targets the left dorsolateral prefrontal cortex (DLPFC), a brain region involved in mood regulation, decision-making, and emotional processing. By stimulating underactive neural circuits in this area, TMS helps restore more typical brain activity patterns.

The connection between TMS for depression and potential anxiety improvement comes from two important observations. First, depression and anxiety are highly comorbid conditions. Research estimates that roughly 60% of individuals with major depression also meet criteria for an anxiety disorder. When TMS successfully treats depression, the accompanying anxiety symptoms often improve as well, even though anxiety was not the direct treatment target.

Second, the brain circuits involved in depression and anxiety are closely interconnected. The prefrontal cortex helps regulate the amygdala, the brain's fear and threat-detection center. When TMS strengthens prefrontal cortex activity, it may also improve the brain's ability to regulate anxiety responses. This neurological overlap helps explain why patients receiving TMS for depression frequently report reduced anxiety as a secondary benefit.

It is important to understand that this secondary improvement in anxiety symptoms during depression treatment is different from using TMS specifically to treat an anxiety disorder. The distinction matters for setting accurate expectations and for understanding what current evidence supports.

What Research Shows About TMS and Anxiety

A growing body of research has examined whether TMS can directly reduce anxiety symptoms. While results are encouraging, the evidence has not yet reached the level required for FDA clearance.

Meta-Analyses and Systematic Reviews

A 2019 meta-analysis published in Brain and Behavior (Cirillo et al., 2019) pooled data from multiple studies examining repetitive TMS (rTMS) for anxiety symptoms, with findings most robust for PTSD and generalized anxiety disorder (GAD). The analysis found a statistically significant reduction in anxiety measures among patients who received active TMS compared to sham (placebo) stimulation. However, the authors noted significant variability between studies in terms of protocols, brain targets, and patient populations, making it difficult to draw definitive conclusions about optimal treatment approaches.

Additional systematic reviews have examined the evidence for rTMS in treating anxiety disorders. These reviews confirm that preliminary findings suggest rTMS may have anxiolytic effects, but emphasize that most studies to date have been small, used varied protocols, and lacked the large-scale randomized controlled trials needed to establish TMS as a standard anxiety treatment.

Stimulation Targets for Anxiety

One area of active research involves identifying the best brain target for anxiety-related TMS. While standard depression protocols stimulate the left DLPFC, some anxiety research has focused on the right DLPFC instead. The right prefrontal cortex plays a different role in emotional processing and may be more directly involved in anxiety regulation. Some studies have also explored low-frequency stimulation of the right DLPFC, which decreases activity in that region rather than increasing it, based on the theory that overactivity in right prefrontal circuits contributes to anxiety.

Other researchers have investigated stimulating different brain regions entirely, including the ventromedial prefrontal cortex and areas involved in fear extinction. These approaches remain experimental, and no single protocol has emerged as clearly superior for anxiety treatment.

Limitations of Current Evidence

Several important limitations apply to the existing research on TMS for anxiety:

Most studies have been relatively small, with fewer than 50 participants per group.
Study designs, stimulation parameters, and treatment durations vary widely, making direct comparisons difficult.
Many studies have examined anxiety symptoms in patients who also have depression, making it hard to separate the direct anti-anxiety effect from improvement secondary to depression treatment.
Long-term follow-up data on TMS for anxiety is limited.
No large-scale, multi-site randomized controlled trial focused specifically on TMS for a primary anxiety disorder has been completed.

These limitations do not mean TMS is ineffective for anxiety. They mean the evidence is not yet strong enough to support FDA clearance or to establish standardized treatment protocols for anxiety disorders.

The Difference Between FDA-Cleared and Off-Label Use

Understanding the distinction between FDA-cleared and off-label use is essential for making informed treatment decisions. The FDA has cleared TMS for two psychiatric indications: major depressive disorder (specifically treatment-resistant depression) and obsessive-compulsive disorder. These clearances were based on large clinical trials that demonstrated safety and efficacy for these specific conditions.

Off-label use means applying a treatment for a condition or in a manner not specifically approved by the FDA. Off-label prescribing is common across all areas of medicine. Many widely used medications are prescribed off-label based on clinical judgment and emerging evidence. Off-label use is legal and sometimes clinically appropriate, but it carries important implications:

The evidence supporting off-label use is typically less robust than for approved indications.
Insurance coverage for off-label use may be limited or unavailable.
Patients should be clearly informed that the use is off-label and what that means for expected outcomes.

At Diamond Edge TMS, Dr. Jerald Block ensures that patients understand exactly what TMS is and is not approved to treat. If a patient's primary concern is anxiety rather than depression, Dr. Block will discuss the current state of evidence, the off-label nature of TMS for anxiety, and whether other established treatments should be tried first or used in combination.

When TMS Might Help with Anxiety Symptoms

While TMS is not FDA-cleared for anxiety, there are clinical scenarios in which TMS treatment may lead to meaningful anxiety improvement.

Comorbid Depression and Anxiety

The most well-supported scenario is when a patient has both major depression and significant anxiety symptoms. When TMS is prescribed to treat the depression (an FDA-cleared use), the accompanying anxiety often improves as well. This is not an off-label use of TMS for anxiety; rather, it is a common secondary benefit of treating the underlying depression. For patients in the Vancouver, WA area whose anxiety is closely tied to their depression, this represents a legitimate reason to consider TMS.

Treatment-Resistant Anxiety with Depression

Some patients have tried multiple medications and therapy approaches without adequate relief from either their depression or anxiety. For these individuals, TMS for treatment-resistant depression may also address the anxiety component that has been similarly resistant to other interventions. Diamond Edge TMS sees patients in this situation regularly and can help evaluate whether TMS is a reasonable next step.

When TMS May Not Be the Right Choice for Anxiety

If a patient has a primary anxiety disorder without significant depression, TMS would be an off-label treatment with less supporting evidence. In these cases, it is generally more appropriate to first pursue established anxiety treatments, including cognitive behavioral therapy, exposure therapy, and medication management. Dr. Block may discuss TMS as a possibility if standard treatments have been exhausted, but will be transparent about the limitations of current evidence.

Combining TMS with Psychotherapy for Anxiety

One of the most promising approaches for addressing anxiety in TMS patients involves combining TMS treatment with psychotherapy. Research suggests that TMS may enhance the brain's capacity for learning and neuroplasticity, potentially making patients more responsive to therapeutic interventions like cognitive behavioral therapy (CBT) or exposure-based treatments.

When TMS improves prefrontal cortex function and reduces depressive symptoms, patients often find they can engage more fully in therapy. The improved concentration, energy, and emotional regulation that come with successful TMS treatment can remove barriers that previously made therapy less effective. For patients whose anxiety has been difficult to treat with therapy alone, the combination of TMS (for their comorbid depression) plus ongoing psychotherapy may produce better results than either approach in isolation.

Diamond Edge TMS takes a comprehensive approach to psychiatric care. Rather than viewing TMS as a standalone solution, Dr. Block works with patients to develop treatment plans that may include TMS alongside psychotherapy, medication management, and lifestyle modifications. This integrated approach recognizes that anxiety and depression are complex conditions that often benefit from multiple treatment modalities working together.

Frequently Asked Questions

Is TMS FDA-cleared for anxiety?

No. TMS is FDA-cleared for major depressive disorder and obsessive-compulsive disorder only. Any use of TMS specifically to treat anxiety is considered off-label. While emerging research suggests TMS may reduce anxiety symptoms, the evidence has not yet met the threshold for FDA clearance for any anxiety disorder.

Can TMS make anxiety worse?

In clinical studies, TMS has generally not been shown to worsen anxiety. Some patients experience mild, temporary discomfort during treatment sessions, such as scalp sensation or headache, but these are typically well-tolerated. If you have concerns about how TMS might affect your anxiety, discuss them with your psychiatrist during the consultation.

Will my insurance cover TMS if my main problem is anxiety?

Insurance coverage for TMS is typically limited to FDA-cleared indications, primarily treatment-resistant depression. If your psychiatrist determines that you have comorbid depression that qualifies for TMS, your insurance may cover the treatment even if anxiety is also a significant concern. Diamond Edge TMS can help you understand your coverage options during the consultation process.

How is TMS for anxiety different from TMS for depression?

Standard TMS for depression targets the left dorsolateral prefrontal cortex with high-frequency stimulation. Research on TMS for anxiety has explored different approaches, including targeting the right DLPFC or using low-frequency protocols. However, no standardized protocol for anxiety has been established, which is one reason TMS is not yet FDA-cleared for anxiety disorders.

Should I try other treatments before considering TMS for anxiety?

Generally, yes. Established first-line treatments for anxiety, including cognitive behavioral therapy, exposure therapy, and medications like SSRIs or SNRIs, have strong evidence behind them and should typically be tried first. TMS may be worth discussing if you have treatment-resistant depression with co-occurring anxiety, or if standard anxiety treatments have not provided adequate relief. Dr. Block can help you evaluate your options based on your specific clinical history.

What should I ask my doctor about TMS and anxiety?

Key questions to discuss include whether your anxiety is comorbid with depression (which may make TMS more relevant), what treatments you have already tried, whether TMS would be used on-label for depression or off-label for anxiety, what results are realistic based on current evidence, and what your insurance is likely to cover. A thorough consultation at Diamond Edge TMS will address all of these questions.

Ready to take the next step?

Diamond Edge TMS is accepting new patients in Vancouver, WA.

Request an appointment or call (360) 838-3654.